TrumpRx Launch 2025: Pfizer Deal Delivers Up to 85% Drug Price Cuts, Ignites PFE Stock Rally and Medicaid Savings
The intersections of policy, pharma, and markets—from the Affordable Care Act’s rollout to the Ozempic supply chain saga—few announcements blend political theater with tangible relief like the Trump administration’s latest salvo on drug prices. On September 30, 2025, President Donald […]










